Literature DB >> 11602213

Activin A serum levels and aging of the pituitary-gonadal axis: a cross-sectional study in middle-aged and elderly healthy subjects.

A Baccarelli1, P S Morpurgo, A Corsi, I Vaghi, M Fanelli, G Cremonesi, S Vaninetti, P Beck-Peccoz, A Spada.   

Abstract

Aim of the study was to investigate activin A serum concentration in healthy adult males and post-menopausal females over a wide age-range and its correlation to gonadotropins, inhibin B and testosterone concentrations. The study included 73 males (aged 30-101 years) and 42 postmenopausal females (aged 50-104 years). Blood samples were collected after an overnight fast to measure serum activin A, inhibin B, LH, FSH, and gonadal steroid levels. A significant increase in serum activin A levels over age in both genders, especially in the oldest age-groups, was observed. Serum inhibin B and testosterone concentrations showed a sharp decrease in male subjects, reflecting the age-related decrease of testicular function and by consequence serum FSH and LH significantly increased. In female subjects LH and FSH levels were very high in subjects in their 50s and showed a continuous decline due to pituitary aging. Simple and multivariable regression analyses demonstrated the lack of correlation between activin A and FSH in both males and females. In conclusion, a steep increase in activin A levels is present during aging in both genders, especially in the last decades of life. The physiologic role and site of production of activin A in old subjects remain to be clarified.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602213     DOI: 10.1016/s0531-5565(01)00117-6

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  20 in total

1.  Loss of BMPR2 leads to high bone mass due to increased osteoblast activity.

Authors:  Jonathan W Lowery; Giuseppe Intini; Laura Gamer; Sutada Lotinun; Valerie S Salazar; Satoshi Ote; Karen Cox; Roland Baron; Vicki Rosen
Journal:  J Cell Sci       Date:  2015-02-06       Impact factor: 5.285

2.  Regulation of muscle mass by follistatin and activins.

Authors:  Se-Jin Lee; Yun-Sil Lee; Teresa A Zimmers; Arshia Soleimani; Martin M Matzuk; Kunihiro Tsuchida; Ronald D Cohn; Elisabeth R Barton
Journal:  Mol Endocrinol       Date:  2010-09-01

Review 3.  Advanced paternal age and reproductive outcome.

Authors:  Zofnat Wiener-Megnazi; Ron Auslender; Martha Dirnfeld
Journal:  Asian J Androl       Date:  2011-12-12       Impact factor: 3.285

Review 4.  Effects of aging on the male reproductive system.

Authors:  Sezgin Gunes; Gulgez Neslihan Taskurt Hekim; Mehmet Alper Arslan; Ramazan Asci
Journal:  J Assist Reprod Genet       Date:  2016-02-11       Impact factor: 3.412

5.  Integrated expression analysis of muscle hypertrophy identifies Asb2 as a negative regulator of muscle mass.

Authors:  Jonathan R Davey; Kevin I Watt; Benjamin L Parker; Rima Chaudhuri; James G Ryall; Louise Cunningham; Hongwei Qian; Vittorio Sartorelli; Marco Sandri; Jeffrey Chamberlain; David E James; Paul Gregorevic
Journal:  JCI Insight       Date:  2016-04-21

6.  Circulating activin-A is elevated in postmenopausal women with low bone mass: the three-month effect of zoledronic acid treatment.

Authors:  A D Anastasilakis; S A Polyzos; P Makras; A Gkiomisi; M Savvides; A Papatheodorou; E Terpos
Journal:  Osteoporos Int       Date:  2012-11-03       Impact factor: 4.507

7.  Effects of the activin A-myostatin-follistatin system on aging bone and muscle progenitor cells.

Authors:  Matthew Bowser; Samuel Herberg; Phonepasong Arounleut; Xingming Shi; Sadanand Fulzele; William D Hill; Carlos M Isales; Mark W Hamrick
Journal:  Exp Gerontol       Date:  2012-11-21       Impact factor: 4.032

Review 8.  Sex differences in health and aging: a dialog between the brain and gonad?

Authors:  Steven N Austad
Journal:  Geroscience       Date:  2019-06-26       Impact factor: 7.713

Review 9.  Muscle wasting in disease: molecular mechanisms and promising therapies.

Authors:  Shenhav Cohen; James A Nathan; Alfred L Goldberg
Journal:  Nat Rev Drug Discov       Date:  2015-01       Impact factor: 84.694

Review 10.  Possible Role of Activin in the Adiponectin Paradox-Induced Progress of Alzheimer's Disease.

Authors:  Makoto Hashimoto; Gilbert Ho; Shuei Sugama; Takato Takenouchi; Masaaki Waragai; Hiromu Sugino; Satoshi Inoue; Eliezer Masliah
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.